{
    "Trade/Device Name(s)": [
        "VITROS Chemistry Products ECO Slides"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K120765",
    "Predicate Device Reference 510(k) Number(s)": [
        "K001133"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KHS"
    ],
    "Summary Letter Date": "September 27, 2012",
    "Summary Letter Received Date": "October 1, 2012",
    "Submission Date": "March 12, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.1160"
    ],
    "Regulation Name(s)": [
        "Bicarbonate/carbon dioxide test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Carbon dioxide"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITROS 250",
        "VITROS 350",
        "VITROS 950",
        "VITROS 5,1 FS",
        "VITROS 4600 Chemistry Systems",
        "VITROS 5600 Integrated System"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic detection",
        "Reflectance spectrophotometry"
    ],
    "Methodologies": [
        "Endpoint enzymatic assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Slide"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS Chemistry Products ECO Slides for quantitative measurement of total carbon dioxide in serum and plasma using enzymatic detection on VITROS Chemistry Systems.",
    "Indications for Use Summary": "For in vitro diagnostic use to quantitatively measure total carbon dioxide (CO2) concentration in serum and plasma; used in diagnosis and treatment of disorders associated with changes in body acid-base balance.",
    "fda_folder": "Clinical Chemistry"
}